Skip to main content

Table 2 Effects of K30, KL30 and K50 on heart rates (Mean ± SD) measured in 6 dogs using crossover design

From: Serum concentration of ketamine and antinociceptive effects of ketamine and ketamine-lidocaine infusions in conscious dogs

 

K30

KL30

K50

Baseline

79 ± 6

77 ± 7

81 ± 6

20 min

113 ± 24a

101 ± 19a

113 ± 22a

40 min

104 ± 16a

99 ± 18a

123 ± 19abc

60 min

105 ± 15a

104 ± 260a

124 ± 23abc

90 min

113 ± 15a

107 ± 21a

127 ± 25ac

120 min

106 ± 19a

98 ± 20a

114 ± 14ac

140 min

93 ± 20

93 ± 12a

99 ± 15a

160 min

86 ± 14

94 ± 11a

102 ± 25ab

  1. K30 Ketamine 0.5 mg/kg loading dose followed by 30 μg/kg/min CRI, KL30 Ketamine 0.5 mg/kg loading dose followed by 30 μg/kg/min and lidocaine hydrochloride 2 mg/kg loading dose followed by 100 μg/kg/min CRI, K50 0.5 mg/kg loading dose followed by 50 μg/kg/min CRI. adenotes significant difference from baseline within same treatment, bdenotes significant difference from K30 at corresponding values, cdenotes significantly different from KL30 at corresponding time points. Overall significance was set at a value of P < 0.05